vitro diagnostic substances, reagents, test kits and sets
ID: N3239825Q0154Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE NAVYNAVAL MEDICAL RESEARCH CENTERSILVER SPRING, MD, 20910-7500, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Defense, through the Naval Medical Research Center, is seeking proposals for a Women-Owned Small Business (WOSB) contract focused on procuring in-vitro diagnostic substances, reagents, and test kits, specifically targeting Biofire Defense products. This procurement is critical for developing reagents used in biological defense against warfare agents, with a total contract value of $64,978.00 for the unique 10x Buffer with BSA 50mM Mg2Cl2, which is essential for operational effectiveness. Interested vendors must submit their offers by March 8, 2025, at 2:00 PM local time, and can direct inquiries to Deborah Sharpe at deborah.m.sharpe2.civ@health.mil or 301-319-9948.

    Point(s) of Contact
    Files
    Title
    Posted
    The Naval Medical Research Command (NMRC) in Silver Spring, MD seeks to acquire a reagent component, specifically the 10x Buffer with BSA 50mM Mg2Cl2, manufactured solely by BioFire Diagnostics/BioFire Defense. This procurement is essential for developing reagents used in biological defense against warfare agents. A Firm Fixed Price contract totaling $64,978.00 is proposed, which falls under a sole source justification due to the unique solution provided by BioFire, critical for operational effectiveness in the field. The justification cites statutory exceptions that allow for this non-competitive acquisition, emphasizing that other suppliers cannot match the necessary specifications without compromising the quality of the reagents involved. Despite market research indicating no alternative sources have expressed interest, the acquisition will be posted publicly to encourage potential future suppliers. The NMRC posits that any transition to different vendors would necessitate re-optimization, adversely affecting ongoing operations. Finally, the contracting officer will ensure the anticipated costs are fair and reasonable and will assess future acquisition strategies should alternative sources emerge.
    The document outlines a solicitation for a Women-Owned Small Business (WOSB) contract focused on procuring commercial products and services related to vitro diagnostic substances, reagents, and test kits. The requisition number is N3239825Q0154, with a due date for offers on March 8, 2025, at 2:00 PM local time. Key items include specific Biofire Defense products, with defined quantities, price arrangements, and delivery instructions to the Naval Medical Research Center in Silver Spring, MD. Inspection and acceptance will occur at designated locations upon delivery. The document includes standardized clauses from the Federal Acquisition Regulation (FAR) and Defense Federal Acquisition Regulation Supplement (DFARS), ensuring compliance with federal regulations concerning procurement processes. It emphasizes the significance of maintaining equitable access and opportunity for WOSB and economically disadvantaged counterparts. Given its structure and content, the document serves as an important tool for enhancing small business participation in federal contracting, aimed particularly at supporting the development and growth of women-owned enterprises within the government contracting space.
    Lifecycle
    Title
    Type
    Similar Opportunities
    Next Sequencing 2000 System
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center, is soliciting proposals for the procurement of the NextSeq 2000 Sequencing System, specifically targeting women-owned small businesses (WOSB). This solicitation outlines the requirements for delivery, acceptance, and compliance with federal regulations, emphasizing firm fixed pricing and the need for unique identifiers for items valued at $5,000 or more. The NextSeq 2000 Sequencing System is crucial for advanced genomic research and analysis, supporting the Department's mission in medical research and development. Interested vendors should contact Deborah M. Sharpe at deborah.m.sharpe2.civ@health.mil or Stephanie Gray at Stephanie.Gray@med.navy.mil for further details, with submissions expected to adhere to the outlined guidelines and deadlines.
    Notice of Intent to Sole Source to Extend Services for N6264520P0020 - Molecular Assay-Analyzers
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), intends to issue a sole source bridge contract to BioFire Defense, LLC for the provision of a molecular diagnostic laboratory analyzer, along with necessary assays, reagents, and consumables at Naval Hospital Camp Pendleton and Naval Medical Center Portsmouth. The contract, which is set to run from April 16, 2025, to October 15, 2025, with an option for an additional six months, requires the analyzer to perform a variety of tests using polymerase chain reaction (PCR) technology, including respiratory, blood culture, gastrointestinal, and meningitis/encephalitis assays, while ensuring compliance with FDA regulations. This procurement is critical for maintaining effective diagnostic capabilities within military medical facilities, and interested vendors must submit capability statements by February 28, 2025, as the procurement will not be open for competitive proposals. For further inquiries, vendors can contact Margaret Suever at margaret.a.suever.civ@health.mil or by phone at 210-952-8283.
    SOLICITATION - W912CH-25-Q-0004 - TESTING KIT,PETROLE - NSN: 6630-01-165-7133
    Buyer not available
    The Department of Defense, through the Army Contracting Command at Detroit Arsenal, is soliciting proposals for the procurement of 28 units of a petroleum testing kit, identified by NSN: 6630-01-165-7133. This solicitation, W912CH-25-Q-0004, specifies that the contract will be a Firm Fixed Price (FFP) purchase order, with an option for an additional 28 units, and is restricted to the manufacturer's part number SC-B/2HB-C-3D. The testing kits are crucial for chemical analysis in military applications, ensuring compliance with operational standards. Interested offerors must submit their proposals via email by March 5, 2025, at 5:00 PM EST, and should ensure they are registered in the System for Award Management (SAM) to be eligible for consideration. For further inquiries, contact Diana Jones at diana.jones47.civ@army.mil or Katherine E. MacFarland at katherine.e.macfarland.civ@army.mil.
    Microbial Testing Supplies - Bridge Contract
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    6550--Microbiology Media Reagents and Supplies
    Buyer not available
    The Department of Veterans Affairs is soliciting offers for a Blanket Purchase Agreement (BPA) to provide Microbiology Media, Reagents, and Supplies for the VA San Diego Healthcare System. This procurement aims to establish a single Firm-Fixed Price contract to secure essential microbiology items necessary for the VA's pathology and laboratory services, with a focus on FDA-approved products capable of conducting various bacterial culture tests. Interested vendors must submit their quotations electronically by 1:00 PM Pacific Time on February 25, 2025, referencing solicitation number 36C26225Q0470, and can contact Contract Specialist Samuel Han at Samuel.Han@va.gov or 562-766-2314 for further inquiries.
    6640--FY25 Q3 Micro Molecular Testing (VA-25-00029953)
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Micro Molecular Testing supplies for the West Palm Beach VA Hospital, under Solicitation No. 36C24825Q0395. The procurement includes various laboratory items and equipment, such as testing kits and the leasing of laboratory instruments, with a requirement for vendors to be Authorized Distributors and provide proof of their status. This initiative is part of the VA's commitment to enhancing its laboratory capabilities to effectively serve veterans. Interested vendors must submit their quotations via email by March 12, 2025, at 2:00 PM Eastern Time, and are encouraged to stay updated on any changes to the solicitation through the Beta-Sam website. For further inquiries, vendors can contact Contract Officer David Henry at David.Henry3@va.gov or by phone at 561-631-3352.
    10--BUFFER ASSEMBLY,REC
    Buyer not available
    The Department of Defense, through the Defense Logistics Agency (DLA Land and Maritime), is seeking proposals for the procurement of a Buffer Assembly, REC, under a Combined Synopsis/Solicitation notice. This opportunity is specifically set aside for SBA Certified Women-Owned Small Businesses (WOSB) and falls under the NAICS code 332994, which pertains to Small Arms, Ordnance, and Ordnance Accessories Manufacturing. The Buffer Assembly is a critical component in the weapons industry, contributing to the functionality and reliability of military equipment. Interested vendors should direct any inquiries regarding this solicitation to the buyer listed in the solicitation document via email at DibbsBSM@dla.mil, and further details can be accessed through the DIBBS website.
    6550--Reagents and consumables
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide reagents and consumables for the VA Greater Los Angeles Healthcare System under solicitation number 36C26225Q0514. This procurement aims to support next-generation sequencing testing, requiring specific reagents compatible with Ion Torrent systems for analyzing myeloid and solid tumor DNA and RNA, as detailed in the attached Statement of Work. The selected contractor will play a crucial role in enhancing healthcare services through advanced genomic testing capabilities, ensuring compliance with VA policies and security protocols. Proposals are due by February 27, 2025, at 9:00 AM PST, and interested parties should direct inquiries to Carlos Magana at carlos.magana@va.gov.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    Biotin Molecules
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking suppliers for biotin molecules through a Combined Synopsis/Solicitation. The procurement aims to acquire analytical laboratory instruments and supplies, categorized under NAICS code 334516 and PSC code 6640, which are essential for various laboratory applications. These biotin molecules are crucial for biochemical research and applications, supporting the Army's ongoing scientific endeavors. Interested vendors can reach out to Carl Lundell at carl.lundell@westpoint.edu or by phone at 845.938.8298, or Joy Davis at joy.l.davis18.civ@army.mil or 315.772.9900 for further details.